According to a new report from Intel Market Research, the global Josamycin Market was valued at USD 320 million in 2024 and is projected to reach USD 510 million by 2034, growing at a robust CAGR of 5.1% during the forecast period. The market growth is driven by increasing antibiotic resistance concerns, rising prevalence of bacterial infections, and expanding applications in emerging markets....
English
Indonesia
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)